Evoke Pharma Inc (EVOK) Stock Analysis

Evoke Pharma Inc (EVOK) is a publicly traded company in the HEALTHCARE sector. It trades at $11.00. This page summarizes the public market data, fundamentals, and frequently asked questions for EVOK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $11.00

Market Sentiment

Evoke Pharma Inc currently has a Bearish sentiment score of -0.43.

About Evoke Pharma Inc

Evoke Pharma, Inc. is a specialty pharmaceutical company based in Solana Beach, California, focused on addressing unmet medical needs in gastroenterological diseases. The company’s flagship product, Gimoti, represents a novel nasal formulation of metoclopramide designed to effectively treat gastroparesis in diabetic patients, highlighting Evoke's commitment to innovative therapeutic solutions. With a strategic emphasis on expanding its portfolio in the gastrointestinal sector, Evoke is poised...

GNG Research Analysis

GNG Research scores Evoke Pharma Inc (EVOK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EVOK.

Frequently Asked Questions

Does EVOK pay dividends?

Evoke Pharma Inc (EVOK) does not currently pay a regular dividend.